Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 17513814

Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2007 May 20
First author
Eckardt JR

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2007 Aug 1;25(22):3387.
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null

Authors and identifiers

  1. name
    Eckardt JR
    type
    Author
  2. name
    von Pawel J
    type
    Author
  3. name
    Pujol JL
    type
    Author
  4. name
    Papai Z
    type
    Author
  5. name
    Quoix E
    type
    Author
  6. name
    Ardizzoni A
    type
    Author
  7. name
    Poulin R
    type
    Author
  8. name
    Preston AJ
    type
    Author
  9. name
    Dane G
    type
    Author
  10. name
    Ross G
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Eckardt JR
    type
    Author
  2. name
    von Pawel J
    type
    Author
  3. name
    Pujol JL
    type
    Author
  4. name
    Papai Z
    type
    Author
  5. name
    Quoix E
    type
    Author
  6. name
    Ardizzoni A
    type
    Author
  7. name
    Poulin R
    type
    Author
  8. name
    Preston AJ
    type
    Author
  9. name
    Dane G
    type
    Author
  10. name
    Ross G
    type
    Author
bibliography ids
  1. nci-bib-4e5f714b814141f6068baae3
book metadata
content sha256
8a860ac882e408807f496ecdcd00d6f79d0456ff87ee0b80b9ebb8babd859449
document type
citation
dois
  1. 10.1200/JCO.2006.08.3998
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:17513814
immutable id
pubmed:17513814@8a860ac882e408807f496ecdcd00d6f79d0456ff87ee0b80b9ebb8babd859449
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
15
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2086-92
volume
25
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2007 Aug 1;25(22):3387.
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
outcomes validated
false
pmid
17513814
provenance
batch id
de363a11f4b1613edab0
provider
NCBI PubMed ESummary
record sha256
c1df0a1fc062f5d95a02108ea476d46ed0b1ca75a35521b70bd65233085a3d77
response sha256
a83f066085229c55d3d0ec880c129c835ac872440e73f5fc2b7131ecfb2a254f
retrieved at
2026-09-09T23:46:14.107379+00:00
publication date
display
2007 May 20
precision
day
year
2007
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/17513814/
title
Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer.

Preserved source evidence · Not medical advice